OCUL – ocular therapeutix, inc. (US:NASDAQ)
Stock Stats
News
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Ocular Therapeutix™ Announces First Patient Randomized in HELIOS-3 Phase 3 Registrational Program for AXPAXLI™ in NPDR
Ocular Therapeutix (NASDAQ:OCUL) was upgraded by analysts at Wall Street
Ocular Therapeutix (OCUL) Soars 5% Ahead of Health Conferences [Yahoo! Finance]
Form 4 OCULAR THERAPEUTIX, INC For: Nov 24 Filed by: Nayak Sanjay
Form 4 OCULAR THERAPEUTIX, INC For: Nov 24 Filed by: Dugel Pravin
Form 4 OCULAR THERAPEUTIX, INC For: Nov 24 Filed by: Kaiser Peter
Form 4 OCULAR THERAPEUTIX, INC For: Nov 24 Filed by: Heier Jeffrey S.
Form 144 OCULAR THERAPEUTIX, INC Filed by: Dugel Pravin
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.